Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM5 | Q9NZQ8 | 3/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | BRAF | P15056 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2464029 | 0.87 | PIK3CA (0.37) | TRPM5SLC6A2SLC6A4SLC6A3TRPA1 | |
| SCHEMBL2461256 | 0.77 | AKT2 (0.43) | — | |
| SCHEMBL16573979 | 0.74 | TRPM5 (0.37) | TRPM5SLC6A2SLC6A4SLC6A3TRPA1 | |
| SCHEMBL26260180 | 0.73 | CYP1A2 (0.46) | ABL1CHEK1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL2458539 | 0.72 | DYRK1A (0.38) | SLC6A2SLC6A4SLC6A3ABL1CHEK1 | |
| SCHEMBL2458237 | 0.72 | ABL1 (0.40) | TRPM5SLC6A2SLC6A4SLC6A3TRPA1 | |
| SCHEMBL26260213 | 0.72 | ESR1 (0.41) | ABL1CHEK1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL2457802 | 0.71 | NISCH (0.45) | TRPM5TRPA1ABL1CYP1A2CYP3A4 | |
| SCHEMBL2455990 | 0.70 | ALDH1A1 (0.36) | ABL1CHEK1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL2459020 | 0.69 | CYP11B1 (0.57) | CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110237633-A1 | SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2011-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237633-A1 | SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY | HGF, HDGF, MET | TRPM5 4109/4885SLC6A2 3628/4885SLC6A4 3754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.